Effect of Foot Reflexology on Anxiety
REFLEX-ANS
The Use of Foot Reflexology in Alleviating Anxiety Symptoms: A Randomized Clinical Trial
1 other identifier
interventional
44
1 country
1
Brief Summary
This randomized, sham-controlled, parallel, double-blind clinical trial investigates the effects of foot reflexology on anxiety and well-being in adults with anxiety disorders. Participants are randomized (1:1) to receive either standardized foot reflexology or sham massage for 10 sessions (twice per week, 5 weeks). The primary outcome is the change in Beck Anxiety Inventory (BAI) score from baseline to the 10th session. Secondary outcomes include BAI score at 30-day follow-up, relaxation and well-being assessed immediately after each session with the Profile of Mood States (POMS - Brazilian version, Tension-Anxiety subscale), and incidence of adverse events. It is hypothesized that foot reflexology will result in a greater reduction of anxiety symptoms compared to sham massage.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 30, 2025
CompletedFirst Submitted
Initial submission to the registry
August 25, 2025
CompletedFirst Posted
Study publicly available on registry
September 8, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 5, 2025
CompletedNovember 28, 2025
November 1, 2025
4 months
August 25, 2025
November 24, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Reduction of Anxiety Symptoms (BAI)
Anxiety symptom variation was assessed using the Beck Anxiety Inventory (BAI), a validated and widely used scale for measuring the intensity of anxiety symptoms. The total score ranges from 0 to 63, with higher scores indicating greater anxiety. The analysis will compare the scores obtained in the first session (baseline), the fifth session, and the tenth intervention session.
Baseline, after 5 sessions and after 10 sessions (approximately 5 weeks).
Secondary Outcomes (2)
Reduction of tension-anxiety levels (Profile of Mood States - POMS, reduced version)
Baseline, after 5 sessions (approximately 2.5 weeks), and after 10 sessions (approximately 5 weeks).
Recording of adverse effects related to the intervention
Throughout the intervention period (10 sessions - approximately 5 weeks).
Study Arms (2)
Foot Reflexology
EXPERIMENTALParticipants will receive 10 foot reflexology sessions, administered twice a week, each lasting approximately 30 minutes. The technique will be performed on specific reflexology points on the feet, according to protocols described in the scientific literature, aiming to reduce anxiety symptoms.
Sham Reflexology
SHAM COMPARATORParticipants will receive 10 simulated intervention sessions, administered twice a week, each lasting approximately 30 minutes. The technique will consist of light, superficial touches to the feet, without stimulating reflexology points, with the aim of simulating the intervention without specific therapeutic effects.
Interventions
A complementary technique that involves applying pressure to reflexology points on the feet. In this study, foot reflexology will be applied in 10 sessions, twice a week, for 30 minutes, aiming to reduce anxiety symptoms.
A simulated procedure consisting of superficial and random maneuvers on the feet, without stimulation of specific reflexology points. Ten sessions will be conducted twice a week, each lasting 30 minutes, for placebo control purposes.
Eligibility Criteria
You may qualify if:
- Age between 18 and 60 years.
- Clinical diagnosis of anxiety disorder confirmed by a healthcare professional (physician or psychologist).
- Score ≥ 11 on the Beck Anxiety Inventory (BAI) in the initial assessment.
- Availability to participate in the 10 proposed sessions.
- Signed informed consent.
You may not qualify if:
- Current use of benzodiazepines, antidepressants, or other psychotropic medications initiated less than 3 months ago.
- Associated diagnosis of psychotic disorder, bipolar disorder, or active suicidal ideation.
- Presence of serious or decompensated medical conditions (e.g., severe cardiovascular disease, uncontrolled epilepsy).
- Simultaneous participation in other complementary therapies (e.g., acupuncture, auriculotherapy, yoga, Reiki) during the study period.
- Pregnant or lactating women.
- Individuals with foot injuries, infections, or diseases that prevent foot reflexology.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centro Universitário Mauricio de Nassau
Vitória da Conquista, Estado de Bahia, 45005338, Brazil
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 25, 2025
First Posted
September 8, 2025
Study Start
July 30, 2025
Primary Completion
November 30, 2025
Study Completion
December 5, 2025
Last Updated
November 28, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share